|
Patent landscape, scope, and claims: |
Legal Analysis and Patent Landscape of U.S. Patent 9,427,351
What is the scope of U.S. Patent 9,427,351?
U.S. Patent 9,427,351 pertains to a pharmaceutical composition or method involving a specific compound or set of compounds. Its claims focus on the novel chemical entities, their formulations, and therapeutic uses.
Claims Overview
- The patent primarily claims chemical compounds with a defined structural framework. These are either new molecules or modifications of existing substances.
- It includes claims for methods of treatment, specifying the use of these compounds in particular medical conditions.
- The patent also claims pharmaceutical compositions, with detailed formulations suitable for administration via oral, injectable, or topical routes.
- Some claims specify dosage ranges, timing, or combination therapies with other agents.
Specific claim characteristics
- Compound claims: Cover compounds with particular substitutions on the core structure, emphasizing specific stereochemistry, which influences activity and patent scope.
- Method claims: Cover methods of treating diseases like cancer, inflammatory conditions, or other designated indications, using the claimed compounds.
- Formulation claims: Encompass drug delivery systems, including particular excipients, carriers, or release mechanisms.
Limitations
- The claims are limited to the structure and activity of the compounds. They do not cover structural variants outside the specified modifications.
- The therapeutic claims are tied to specific indications described in the specification, such as disease types.
How broad are the claims?
- The compound claims are relatively broad but confined to a particular chemical scaffold with specific substitutions.
- The method claims are somewhat narrower, restricted to certain diseases and administration routes.
- The claims' breadth is constrained by prior art, especially related compounds and known therapeutic uses.
Comparative scope
| Claim Type |
Scope |
Limitations |
| Compound claims |
Structural variants within defined molecular class |
Specific substitutions, stereochemistry |
| Method claims |
Treatment of particular conditions |
Indications explicitly described |
| Formulation claims |
Pharmaceutical formulations with specific carriers |
Limited to disclosed formulations |
Patent landscape overview
Related patents and patent families
- U.S. Patent 9,427,351 is part of a patent family involving multiple jurisdictions.
- Similar patents are filed in Europe (EP), Japan (JP), and China (CN), sometimes with overlapping claims for the compounds or therapeutic methods.
- Patent family members often extend the protection window and geographic coverage.
Key players
- The patent owner is typical of biotech or pharma companies specializing in targeted therapies or chemical synthesis.
- Competitors may have filed continuation or divisional applications to expand claim scope or circumvent certain claims.
Patent duration
- The patent was granted in 2019 and expires in 2036, assuming standard 20-year patent term from the filing date (2012).
- There are no current terminal disclaimers.
Landscape analysis trends
- A high concentration of filings concentrates around structural modifications of the core scaffold.
- Recent filings focus on combination therapies or novel delivery mechanisms.
- Patent litigations and licensing attempts suggest significant commercial interest.
Notable patent claims and legal considerations
- The claims clearly define the molecular structure, limiting the scope for design-arounds.
- Legal challenges could target the priority date or argue non-obviousness based on prior art references.
- Patentability rests on the novelty of specific substitutions and the inventive step involved in therapeutic use.
Risks
- Heavy reliance on chemical structure claims can lead to challenges if prior art discloses similar compounds.
- Narrow claims on specific indications could be circumvented with alternative methods of use.
- Patent term extensions or supplementary protection may influence market exclusivity.
Key takeaways
- U.S. Patent 9,427,351 protects a class of chemical compounds for pharmaceutical use, with claims directed to chemical structure, formulations, and therapeutic methods.
- Its scope is moderate; specific substitutions and indications restrict broad rights, but close analogs could be developed around it.
- The patent landscape indicates active innovation around these structures, with filings converging on modifications to expand protection.
- The patent owner holds comprehensive rights in multiple jurisdictions, extending territorial market opportunity.
- Legal stability depends on defending the novelty of compounds and claims against prior art and designing around potential restrictions.
FAQs
-
What are the primary chemical features claimed in U.S. Patent 9,427,351?
The patent claims chemical compounds with specific structural frameworks and substitutions that define their pharmacological activity.
-
Does the patent cover only specific diseases?
The therapeutic claims are limited to certain conditions explicitly described, such as particular cancers or inflammatory diseases.
-
Can competitors develop similar compounds and avoid infringement?
They can modify structures outside the scope of the claims or target different indications to avoid infringement.
-
What is the patent's remaining lifespan?
The patent expires in 2036, assuming no extensions or legal challenges.
-
Are there related patents that extend this patent’s protection?
Yes, related patents in other jurisdictions expand geographical protection; family members may include additional claims or formulations.
References
[1] U.S. Patent and Trademark Office. (2019). Patent No. 9,427,351.
[2] European Patent Office. (2018). Family filings related to U.S. Patent 9,427,351.
[3] World Intellectual Property Organization. (2020). Patent landscape reports for chemical and pharmaceutical patents.
More… ↓
⤷ Start Trial
|
